Search Results 1111-1120 of 19353 for hemoglobin

1. Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (obtained ≤ 14 days prior to randomization). Untransfused platelet count ≥ 75,000 cells/mm^3 (obtained ≤ 14 days prior to ...

2. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   hemoglobin ≥9 g/dL;; serum bilirubin ≤1.5 × upper limit of normal (ULN) or ≤ × ULN for patients with Gilbert's disease;; CrCl ≥30 mL/min as measured by 24 ...

3. Actinium Therapy For Late-stage Aggressive Sarcomas - Mayo Clinic

   Hemoglobin ≥ 8 g/dL 4. Total bilirubin level ≤ 1.5 × upper limit of normal (ULN). 5. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ...

4. A Study to Find the Genetics and Metabolism Dysfunction for Familial Partial Lipodystrophy - Mayo Clinic

   Hemoglobin < 10g%. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date information ...

5. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

   ... hemoglobin level that remains above ≥ 9 g/L for at least 2 weeks). Hematology; Platelet count. < 100 × 10^9/L. Hemoglobin. < 9 g/L. ANC. < 1.5 × 10^9/L.

6. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

   Known history of hemoglobinopathy, hemolytic anemia or sickle cell anemia, or any other traits of hemoglobin abnormalities known to interfere with the ...

7. Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III - Mayo Clinic

   Hemoglobin less than 12 mg/dL. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

8. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Hemoglobin >=8.0 g/dL;; Platelets>= 50 X 10^9/L;; Total bilirubin <=1.5X Upper limit of normal (ULN). Isolated bilirubin >=1.5xULN is acceptable if bilirubin ...

9. Luspatercept-aamt (injection route) - Side effects & uses - Mayo Clinic

   Luspatercept-aamt injection is also used to treat anemia in patients with myelodysplastic syndromes who need regular red blood cell (RBC) transfusions and have ...

10. Myelofibrosis - Diagnosis and treatment - Mayo Clinic

    Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.